Seulki Lee
Chairman, Interim CEO.
Associate Prof. of Radiology, Oncology, Center for Nanomedicine, Johns Hopkins School of Medicine
Former Leader of Theranostic Nanomedicine Section, NIH
Founder of Theraly Fibrosis
Junghee Lim
Intervest, Executive Managing Director
CIO of Intervest global pharmafund
Head of Strategic planning, IsuAbxis, Inc.
Experience in Biotech venture investment
Keele Park
Magna Investment, CEO
Former affiliations:
Samsung Electronics
VP, VGX Pharmaceuticals
Viktor Roschke
Neuraly, CSO, Head R&D
Former VP, CEO Zyngenia, Inc.,
VP, Biopharmaceutical Research at Teva Pharmaceuticals,
VP at Cogenesys, Inc., Director, Human Genome Science
20 years experience in drug development
John Ku
Smilegate Investment, Executive VP
Former Affiliations:
Bain & Co, and Booz-Allen & Hamilton
Investment in more than 30 companies in biotech/healthcare sector.
Support of more than 10 successful IPO and M&A.
Phil Jung
Maryland Venture Fund, Associate
Former Affiliations:
Foundation Capital, Menlo Park, CA, VC Fellow
TDF Ventures, Chevy Chase, MD, Venture Fellow